Abstract:Liquid-liquid phase separation (LLPS) drives the formation of extensive membrane-less compartments to regulate various cellular biological activities both physiologically and pathologically. It has been widely accepted that LLPS is closely related to amyloid diseases and increasing reports have linked this phenomenon to cancers. Mutations of tumor suppressor protein p53 exist in more than half of malignant tumors, making the protein vitally important in cancer research. Recently, p53 was reported to undergo phase separation, which may regulate the function of p53. The molecular mechanism of p53 phase separation and how this process relates to cancer remains largely unclear. Herein, we find that the disordered unstructured basic region (UBR) plays a crucial role in p53 LLPS, driven by electrostatic and hydrophobic interactions. Mutations in the tetramerization domain (TD) disrupt p53 phase separation by preventing the tetramer formation. Furthermore, our results have revealed that, in response to DNA damage in cell, the wild type (WT) p53 undergoes LLPS, while LLPS in oncogenic mutations is diminished or eliminated. The expression of the target gene of p53 decreased significantly with the mutations and cell survival increased with the mutations. Thus, we propose a novel mechanism of p53 carcinogenesis, whereby oncogenic mutations in TD impair the formation of p53 condensates, decreasing the activation of target genes and promoting cancer progression. This study helps to understand the behavior and function of p53 in a different aspect and may provide insights into cancer therapies targeting p53.

What problem does this paper attempt to address?

The core problem that this paper attempts to solve is to explore the molecular mechanism of liquid - liquid phase separation (LLPS) of p53 protein in cells and how this process is associated with the development of cancer. Specifically, the researchers focused on the role of the unstructured basic region (UBR) of p53 protein in phase separation and how oncogenic mutations affect this process. Through these studies, they hope to reveal a new p53 oncogenic mechanism, that is, oncogenic mutations inhibit p53 phase separation by disrupting p53 tetramer formation, thereby reducing the activation of target genes and promoting cancer progression. ### Main research contents: 1. **Contribution of UBR to p53 phase separation**: - The study found that the unstructured basic region (UBR) of p53 protein plays a crucial role in its phase - separation process. UBR is a highly disordered region and can drive p53 phase separation through electrostatic and hydrophobic interactions. 2. **Driving forces for UBR phase separation**: - Through experiments, the researchers confirmed that the phase separation of UBR is mainly driven by electrostatic and hydrophobic interactions. High - salt concentration can significantly inhibit the phase separation of UBR, and 1,6 - hexanediol (a compound that interferes with hydrophobic interactions) can also reduce the phase separation of UBR. 3. **Effect of oncogenic mutations on UBR phase separation**: - The study found that oncogenic mutations (such as R337C, R337P, L344P) inhibit their phase separation by disrupting the tetramer structure of p53. These mutations cause p53 to be unable to form droplet - like condensates, thereby affecting its function. 4. **Relationship between p53 phase separation and DNA damage response**: - In cell experiments, the researchers observed that when cells are stimulated by DNA damage, wild - type p53 (WT - p53) will form droplet - like condensates, and p53 in these condensates is highly phosphorylated and in an activated state. In contrast, p53 with oncogenic mutations cannot form such condensates, resulting in a decreased ability to activate downstream target genes. ### Conclusion: This study reveals the important role of the unstructured basic region (UBR) of p53 protein in phase separation and finds that oncogenic mutations inhibit its phase separation by disrupting the tetramer structure of p53, thereby affecting its function as a transcription factor. This finding provides a new perspective for understanding the behavior and function of p53 in cancer development and may provide new ideas for developing treatment strategies for p53 - related cancers.

Phase separation of p53 induced by its unstructured basic region and prevented by oncogenic mutations in tetramerization domain

Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations

Mechanistic Insight into the Destabilization of P53td Tetramer by Cancer-Related R337H Mutation: a Molecular Dynamics Study.

Oncogenic Phase Transitions: How Mutant p53 Drives Amyloid Formation in p63 and p73 Liquid Droplets

Protein Phase Separation: New Insights into Carcinogenesis

Phosphorylation and specific DNA improved the incorporation ability of p53 into functional condensates

Phase Separation in DNA Damage Response: New Insights into Cancer Development and Therapy

Interplay between posttranslational modifications and liquid‒liquid phase separation in tumors

Functional Diversity of P53 in Human and Wild Animals

Aberrant phase separation and cancer

Targeting mutant p53 stabilization for cancer therapy

[Research Progress in the Role of Liquid-Liquid Phase Separation in Human Cancer]

Full-atomistic Molecular Dynamics Analysis of p53 Active Tetramer

Phase separation-mediated biomolecular condensates and their relationship to tumor

Regulation of P53 Stability As a Therapeutic Strategy for Cancer.

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Phase-Separated Subcellular Compartmentation and Related Human Diseases

Role of liquid-liquid phase separation in cancer: Mechanisms and therapeutic implications

Phase separation in cancer at a glance

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant

The Janus Face of P53-Targeting Ubiquitin Ligases